KR910004191A - 신질환치료제 - Google Patents
신질환치료제 Download PDFInfo
- Publication number
- KR910004191A KR910004191A KR1019900012231A KR900012231A KR910004191A KR 910004191 A KR910004191 A KR 910004191A KR 1019900012231 A KR1019900012231 A KR 1019900012231A KR 900012231 A KR900012231 A KR 900012231A KR 910004191 A KR910004191 A KR 910004191A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- renal disease
- disease treatment
- formula
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 일반식(Ⅰ) :[식중, R1, R2는 각각 동일 내지는 다른 수소, 알킬기 또는 시클로알킬기를 표시하고, X, Y는 각각 동일한 내지는 다른 수소, 알킬기, 히드록시기 또는 알콕시기, 또는 X및Y로 옥소기를 표시한다.]로 대표되는 히단로인 유도체 및 그의 약학적으로 허용되는 염의 적어도 1종을 유효성분으로서 함유하는 것을 특징으로 하는 신질환치료제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1-207699 | 1989-08-09 | ||
| JP1207699A JP2678499B2 (ja) | 1989-08-09 | 1989-08-09 | 尿毒症毒素低下剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR910004191A true KR910004191A (ko) | 1991-03-28 |
| KR0151389B1 KR0151389B1 (ko) | 1998-10-15 |
Family
ID=16544105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019900012231A KR0151389B1 (ko) | 1989-08-09 | 1990-08-09 | 신질환치료제 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5084473A (ko) |
| EP (1) | EP0412940B1 (ko) |
| JP (1) | JP2678499B2 (ko) |
| KR (1) | KR0151389B1 (ko) |
| AT (1) | ATE147625T1 (ko) |
| DE (1) | DE69029693T2 (ko) |
| DK (1) | DK0412940T3 (ko) |
| ES (1) | ES2095870T3 (ko) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2678499B2 (ja) * | 1989-08-09 | 1997-11-17 | 日本臓器製薬 株式会社 | 尿毒症毒素低下剤 |
| US5912261A (en) * | 1994-12-20 | 1999-06-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Carboxyalkyl heterocyclic derivatives |
| US6197806B1 (en) * | 1995-12-20 | 2001-03-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Eliminating agent for activated oxygen and free radicals |
| JPH10182460A (ja) * | 1996-12-27 | 1998-07-07 | Nippon Zoki Pharmaceut Co Ltd | ３−デオキシグルコソン生成阻害剤 |
| AU754989B2 (en) | 1998-11-16 | 2002-11-28 | Nippon Zoki Pharmaceutical Co., Ltd. | A therapeutic agent for intractable vasculitis |
| JP4711523B2 (ja) * | 2001-02-13 | 2011-06-29 | 日本臓器製薬株式会社 | 低アルブミン血症改善剤 |
| TWI353979B (en) | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
| JP2004123735A (ja) * | 2002-09-11 | 2004-04-22 | Nippon Zoki Pharmaceut Co Ltd | 光学活性（ｓ）−ヒダントイン誘導体 |
| JP2004123736A (ja) * | 2002-09-11 | 2004-04-22 | Nippon Zoki Pharmaceut Co Ltd | 光学活性（ｒ）−ヒダントイン誘導体 |
| US20060241163A1 (en) * | 2005-04-20 | 2006-10-26 | Kaoru Okamoto | Optically active (S)-hydantoin derivative |
| US20060241162A1 (en) * | 2005-04-20 | 2006-10-26 | Kaoru Okamoto | Optically active (R)-hydantoin derivative |
| JP4674381B2 (ja) * | 2005-12-13 | 2011-04-20 | 収 伊藤 | 複合オーニング装置及び複数キャンバスの巻取りローラ |
| JP4660616B2 (ja) * | 2009-08-31 | 2011-03-30 | 株式会社東芝 | 基板検査装置 |
| AU2015223908C1 (en) * | 2014-02-26 | 2020-12-03 | Nippon Zoki Pharmaceutical Co., Ltd. | Progress-Suppressing or Improving Agent for Chronic Kidney Disease |
| CN110740729B (zh) | 2017-06-13 | 2023-05-16 | 国立研究开发法人国立癌症研究中心 | 致癌抑制剂 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| JPS59199652A (ja) * | 1983-04-27 | 1984-11-12 | Kyowa Hakko Kogyo Co Ltd | α−ケトカルボン酸塩類の製造方法 |
| JPH0686436B2 (ja) * | 1984-11-15 | 1994-11-02 | 日本臓器製薬株式会社 | 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物 |
| AU578068B2 (en) * | 1984-03-08 | 1988-10-13 | Nippon Zoki Pharmaceutical Co., Ltd. | Hydantoin derivatives and pharmaceutical compositions containing them |
| JPH062748B2 (ja) * | 1984-03-08 | 1994-01-12 | 日本臓器製薬株式会社 | 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物 |
| EP0194226B1 (en) * | 1985-02-06 | 1990-02-07 | Nippon Zoki Pharmaceutical Co. Ltd. | A pharmaceutical composition containing an imidazolidinetrione derivative or pharmaceutically acceptable salt thereof |
| JPH0764729B2 (ja) * | 1985-02-06 | 1995-07-12 | 日本臓器製薬株式会社 | イミダゾリジントリオン誘導体を含有する医薬組成物 |
| JPH0623102B2 (ja) * | 1985-08-22 | 1994-03-30 | 日本臓器製薬株式会社 | 脂質低下剤 |
| US4853401A (en) * | 1987-04-01 | 1989-08-01 | G. D. Searle & Co. | Spiro-hydantoins as aldose reductase inhibitors |
| JP2678499B2 (ja) * | 1989-08-09 | 1997-11-17 | 日本臓器製薬 株式会社 | 尿毒症毒素低下剤 |
-
1989
- 1989-08-09 JP JP1207699A patent/JP2678499B2/ja not_active Expired - Fee Related
-
1990
- 1990-08-07 DK DK90810592.7T patent/DK0412940T3/da active
- 1990-08-07 AT AT90810592T patent/ATE147625T1/de not_active IP Right Cessation
- 1990-08-07 ES ES90810592T patent/ES2095870T3/es not_active Expired - Lifetime
- 1990-08-07 EP EP90810592A patent/EP0412940B1/en not_active Expired - Lifetime
- 1990-08-07 DE DE69029693T patent/DE69029693T2/de not_active Expired - Fee Related
- 1990-08-09 KR KR1019900012231A patent/KR0151389B1/ko not_active IP Right Cessation
- 1990-08-09 US US07/564,520 patent/US5084473A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0412940A3 (en) | 1991-10-23 |
| DE69029693T2 (de) | 1997-05-07 |
| DE69029693D1 (de) | 1997-02-27 |
| JPH0372463A (ja) | 1991-03-27 |
| EP0412940A2 (en) | 1991-02-13 |
| DK0412940T3 (da) | 1997-07-14 |
| US5084473A (en) | 1992-01-28 |
| ES2095870T3 (es) | 1997-03-01 |
| EP0412940B1 (en) | 1997-01-15 |
| KR0151389B1 (ko) | 1998-10-15 |
| JP2678499B2 (ja) | 1997-11-17 |
| ATE147625T1 (de) | 1997-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950017957A (ko) | 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체 | |
| KR910004191A (ko) | 신질환치료제 | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| KR950016738A (ko) | 알쯔하이머 질병의 억제 방법 | |
| KR950016732A (ko) | 피부 및 질의 위축 억제방법 | |
| NO933482L (no) | N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer | |
| KR950016744A (ko) | 트롬빈을 저해하는 방법 | |
| KR950017949A (ko) | 벤조티오펜 화합물과 수용성 사이클로덱스트린의 수용성 내포착물, 및 그의 약학제제 및 제조 방법 | |
| KR950016746A (ko) | 비-펩티드 타키키닌 수용체 길항물질 | |
| KR950016725A (ko) | 폐 고혈압성 질병을 억제하는 방법 | |
| KR930703303A (ko) | 1, 4-벤조티아제핀 유도체 | |
| KR950016731A (ko) | 지루 및 좌창의 억제 방법 | |
| KR950016723A (ko) | 자가면역 질병의 억제 방법 | |
| KR950010892A (ko) | 자궁 섬유증 억제 방법 | |
| KR940005274A (ko) | 쇼그렌(Sjoegren)증후군 치료제 | |
| KR950016740A (ko) | 조직의 불완전한 회복을 저해하는 방법 | |
| KR950016726A (ko) | 기능부전성 자궁 출혈을 억제하는 방법 | |
| KR950016727A (ko) | 트롬보모듈린 발현을 증가시키는 방법 | |
| KR950010889A (ko) | 혈관형성 및 혈관형성성 질병을 억제하는 방법 | |
| KR960007592A (ko) | 신규한 피롤로카바졸 | |
| KR960006915A (ko) | 췌장염의 치료 조성물 | |
| KR927003525A (ko) | 술폰아닐리드 유도체 및 의약 | |
| KR910019632A (ko) | 비스(알킬-치환-4-히드록시페닐티오)알칸 유사체를 유효성분으로 함유하는 백내장 발병 억제용 제약 조성물 | |
| KR950016760A (ko) | 치질 치료제 | |
| KR950016735A (ko) | 터너 증후군의 억제 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20120601 Year of fee payment: 15 |
|
| EXPY | Expiration of term |